Product Code: 137963-08-22
The market is projected to grow at a CAGR of 19.5% during the forecast period of 2022 to 2030. Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. DTC refers to a genetic test that can be completed at home without a health care provider. After collection of the DNA sample the individual can send it to the company. They analyze it and provide a report on genetics. There are many different types of DTC tests available. They can reveal about ancestry, kinship, lifestyle factors and disease risk.
Selective Role of FDA
In general, direct-to-consumer tests for non-medical, general wellness, or low risk medical purposes are not reviewed by the FDA before they are offered. Direct-to-consumer tests for moderate to high risk medical purposes, which may have a higher impact on medical care, are generally reviewed by the FDA to determine the validity of test claims. FDA verifies that whether the test can measure accurate or reliably, whether the measurement is measured at certain health stage & finally the company's claim about the test. Also the test accuracy is measured along with descriptive recording of information. As a matter of policy, the FDA generally does not review some types of tests, called laboratory developed tests (LDTs) that are created and performed in a single laboratory, if they are offered to patients only when prescribed by a health care provider. These tests typically do not have the FDA's independent assurance of the analytical validity, clinical validity, or clear communication of test results. All direct-to-consumer test users, including health care providers and consumers, are strongly encouraged to voluntarily report problems with direct-to-consumer tests directly to the FDA through Medwatch, the FDA's voluntary reporting program.
Privacy is a concern
65% of individuals are willing to use, home Direct to consumer genetic testing service is reported. Privacy is one of the main concerns specifically the potential sharing of data with third parties including consumer health, pharmaceutical & insurance companies. Almost all of the respondents willing to use the service have concerns about a company owning their DNA profiles. In submitting a sample for processing, individuals provide sensitive information not only about themselves but about family members with whom they share a genetic link. Leakage of such data could negatively impact these individuals across a range of areas including employment prospects, relationships and insurance premiums. Cyber security breaches database password & server hacking, storage device theft, and human error or oversight by data custodians themselves represents a threat here.
Increase in willingness to use Direct to consumer Genetic testing
Rising public awareness and acceptance of genetic testing is steadily growing. A national survey revealed that awareness in the US grew drastically, and a social media survey found that 47% of users were familiar with the direct to consumer concept. Across many sectors there is a clear rise in customers seeking tailored products & experiences, with an increasing willingness to pay for the identification & addressing of unique needs. Customers are expressing willingness to undergo testing & pay for genetic testing services. According to a recent survey held in the U.S. 10 sample of 2,000 participants 33% of individuals stated that they would be willing to pay for & use advice provided by a direct to consumer's genetic testing company.
North America dominates the market
North America has a major market of more than 30% in Direct to consumer Genetic testing which is followed by Europe. Globally there are more than 200 companies offering DTC genetic testing services with prominent ones headquartered in North America having no clear majority of the market share held by any specific player. Products such as CentoDx Plus by Centogene AG, Ancestry kit by 23andMe and family finder test, Y-DNA and mtDNA test by GenebyGene, Ltd. are few of the products ordered through different distribution channels. Consumers are buying these services and kits to obtain information related to family lineage, disease risks and personal traits. Along with genetic testing kits, manufacturers and third parties are providing additional services pertaining to interpretation of the raw data. DTC coupled with accessibility through on-line sales channel, procurement of these services/kits has literally become hassle-free with test results delivered at consumers' doorstep. On-line sales as a prime distribution channel expected to grow with the highest CAGR during the forecast period. North America led the DTC genetic testing market in 2017 while Asia Pacific is poised to emerge as the fastest growing region between 2018 and 2026. Availability of wide range of DTC genetic test kits through portals of manufacturers and third-party websites for the consumers to choose from is contributing to the overall remunerative growth of the DTC genetic testing market.
Key players
Key players in this segment include: 23 and Me, Colour Genomics, Counsyl, Gene by Gene, Laboratory Corporation of America, MyMedLab, Mapmygenome India, Positive Bioscience, Quest Diagnostics, Request A Test, Sonora Quest Laboratories LLC, Xcode Life Sciences are some of the leading companies in the global Direct to consumer Genetic testing market.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Direct-To-Consumer (DTC) Genetic Testing market are as follows:
- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Direct-To-Consumer (DTC) Genetic Testing market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Sales Channel
Online Sales
OTC Sales
Doctor's Office
Business Model
Genome Data Bank Material Model
Individual Health Planning Model
Comprehensive Genome Tests Model
Medical Precision Tests Model
Restricted Trait Tests Model
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of COVID-19 Segment (2020-2021; US$ Million )
Pre COVID-19 situation
Post COVID-19 situation
Key questions answered in this report:
- What are the key micro and macro environmental factors that are impacting the growth of Direct-To-Consumer (DTC) Genetic Testing market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Direct-To-Consumer (DTC) Genetic Testing market?
- Which is the largest regional market for Direct-To-Consumer (DTC) Genetic Testing market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Direct-To-Consumer (DTC) Genetic Testing market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Direct-To-Consumer (DTC) Genetic Testing market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Direct-To-Consumer (DTC) Genetic Testing Market
- 2.2. Global Direct-To-Consumer (DTC) Genetic Testing Market, By Sales Channel, 2021 (US$ Million)
- 2.3. Global Direct-To-Consumer (DTC) Genetic Testing Market, By Business Model, 2021 (US$ Million)
- 2.4. Global Direct-To-Consumer (DTC) Genetic Testing Market, By Geography, 2021 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2021
- 2.6. Key Buying Criteria
- 2.7. Key Case Reports
- 2.8. Scenario Analysis
- 2.8.1. Optimistic estimates and analysis
- 2.8.2. Realistic estimates and analysis
- 2.8.3. Pessimistic estimates and analysis
- 2.9. Market Profiling
- 2.10. Sales and Marketing Plan
- 2.11. Top Market Conclusions
- 2.12. Strategic Recommendations
3. Direct-To-Consumer (DTC) Genetic Testing Market: Competitive Analysis
- 3.1. Market Positioning of Key Direct-To-Consumer (DTC) Genetic Testing Market Vendors
- 3.2. Strategies Adopted by Direct-To-Consumer (DTC) Genetic Testing Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Direct-To-Consumer (DTC) Genetic Testing Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Direct-To-Consumer (DTC) Genetic Testing Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
- 4.8. Heptalysis Analysis
- 4.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
5. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Online Sales
- 5.3.2. OTC Sales
- 5.3.3. Doctor's Office
6. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Genome Data Bank Material Model
- 6.3.2. Individual Health Planning Model
- 6.3.3. Comprehensive Genome Tests Model
- 6.3.4. Medical Precision Tests Model
- 6.3.5. Restricted Trait Tests Model
7. Geographic Analysis
- 7.1. Market Overview
- 7.2.Macro Factors versus Market Impact: Dashboard, 2021
- 7.3. Porters Five Force Model Across Geography: Dashboard, 2021
- 7.4. Impact of PESTEL factors Across Geography: Dashboard, 2021
8. North America Direct-To-Consumer (DTC) Genetic Testing Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 8.3. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 8.4.Direct-To-Consumer (DTC) Genetic Testing Market: By Region, 2020-2030, USD (Million)
- 8.4.1.North America
- 8.4.1.1. U.S.
- 8.4.1.1.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 8.4.1.1.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 8.4.1.2. Canada
- 8.4.1.2.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 8.4.1.2.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 8.4.1.3. Rest of North America
- 8.4.1.3.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 8.4.1.3.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
9. UK and European Union Direct-To-Consumer (DTC) Genetic Testing Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.3. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.Direct-To-Consumer (DTC) Genetic Testing Market: By Region, 2020-2030, USD (Million)
- 9.4.1.UK and European Union
- 9.4.1.1. UK
- 9.4.1.1.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.1.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.1.2. Germany
- 9.4.1.2.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.2.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.1.3. Spain
- 9.4.1.3.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.3.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.1.4. Italy
- 9.4.1.4.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.4.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.1.5. France
- 9.4.1.5.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.5.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 9.4.1.6. Rest of Europe
- 9.4.1.6.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 9.4.1.6.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
10. Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.3. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.Direct-To-Consumer (DTC) Genetic Testing Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Asia Pacific
- 10.4.1.1. China
- 10.4.1.1.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.1.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.1.2. Japan
- 10.4.1.2.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.2.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.1.3. India
- 10.4.1.3.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.3.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.1.4. Australia
- 10.4.1.4.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.4.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.1.5. South Korea
- 10.4.1.5.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.5.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 10.4.1.6. Rest of Asia Pacific
- 10.4.1.6.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 10.4.1.6.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
11. Latin America Direct-To-Consumer (DTC) Genetic Testing Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 11.3. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 11.4.Direct-To-Consumer (DTC) Genetic Testing Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Latin America
- 11.4.1.1. Brazil
- 11.4.1.1.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 11.4.1.1.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 11.4.1.2. Mexico
- 11.4.1.2.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 11.4.1.2.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 11.4.1.3. Rest of Latin America
- 11.4.1.3.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 11.4.1.3.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
12. Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market, 2020-2030, USD (Million)
- 12.1. Market Overview
- 12.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 12.3. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 12.4.Direct-To-Consumer (DTC) Genetic Testing Market: By Region, 2020-2030, USD (Million)
- 12.4.1.Middle East and Africa
- 12.4.1.1. GCC
- 12.4.1.1.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 12.4.1.1.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 12.4.1.2. Africa
- 12.4.1.2.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 12.4.1.2.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
- 12.4.1.3. Rest of Middle East and Africa
- 12.4.1.3.1. Direct-To-Consumer (DTC) Genetic Testing Market: By Sales Channel, 2020-2030, USD (Million)
- 12.4.1.3.2. Direct-To-Consumer (DTC) Genetic Testing Market: By Business Model, 2020-2030, USD (Million)
13. Company Profile
- 13.1. 23 and Me
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Colour Genomics
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Counsyl
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Gene by Gene
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Laboratory Corporation of America
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. MyMedLab Mapmygenome India
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Positive Bioscience
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Quest Diagnostics
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Request A Test
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Sonora Quest Laboratories LLC
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Xcode Life Sciences
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives